Acceleration 2013: Nutter Early Stage Life Sciences Conference

Monday, December 9 2013
3:30 pm – 6:30 pm

This event was posted by Nutter McClennen & Fish LLP

Event Inquiries

Location: Nutter McClennen & Fish, Louis D. Brandeis Conference Center, Seaport West, 155 Seaport Boulevard, Boston, MA 02210

Acceleration connects investors, entrepreneurs and industry executives in biotech, pharma, device and healthcare who are focused on innovation and investment for growth. Join key thought leaders to examine exit transactions and how the industry views value creation in a post-ACA world.

 Acceleration 2013
Presented by Nutter McClennen & Fish LLP
together with Halloran Consulting Group and Silicon Valley Bank

Healthcare: Trends in Mergers and Acquisitions
Jonathan Norris
Managing Director
Silicon Valley Bank
Jonathan Norris will present findings from Silicon Valley Bank's annual report on healthcare venture trends, examining early stage investment, venture fundraising, exit deals, and industry forecasts.

How the Affordable Care Act is changing the definition of value for entrepreneurs, investors and acquirers. The panel will explore the impact of the ACA -- with its focus on patient outcomes and cost control -- on the building, financing and acquisition of life science companies.

Speakers include
Stephen Kraus, Partner, Bessemer Venture Partners
Michael Powell, PhD, General Partner, Sofinnova Ventures
Laurel Sweeney, Sr. Director, Health Economics & Reimbursement, Philips Healthcare

Moderated by
Michelle L. Basil, Chair, Nutter Life Sciences Group

Barbara Fox, Ph.D., Founder & CEO of Avaxia Biologics, will be interviewed by Angel investor and Board Member, Henry Kay, to describe the challenges faced, and solutions identified, in conceptualizing, funding and growing a cutting edge biotechnology company.  

 Program followed by cocktails & networking

This free event is available by invitation only.  To request an invitation, please visit or email us at  

Share MassBio